Sanofi (SNYNF)

Market Cap	114.73B -16.0%
Revenue (ttm)	54.85B +5.5%
Net Income	9.17B +40.5%
EPS	7.48 +43.6%
Shares Out	n/a
PE Ratio	12.51
Forward PE	9.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,700
Average Volume	83,581
Open	97.43
Previous Close	95.02
Day's Range	93.75 - 97.43
52-Week Range	90.05 - 122.03
Beta	0.37
RSI	47.56
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, COVID-19 vaccine Nuvaxovid, booster, meningitis, and travel and endemic vaccines, that in...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 74,846
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR